[go: up one dir, main page]

WO2003054021A2 - Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes - Google Patents

Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes Download PDF

Info

Publication number
WO2003054021A2
WO2003054021A2 PCT/ZA2002/000218 ZA0200218W WO03054021A2 WO 2003054021 A2 WO2003054021 A2 WO 2003054021A2 ZA 0200218 W ZA0200218 W ZA 0200218W WO 03054021 A2 WO03054021 A2 WO 03054021A2
Authority
WO
WIPO (PCT)
Prior art keywords
semi
antibody fragment
combinatorial library
avian
immunoglobulin genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ZA2002/000218
Other languages
French (fr)
Other versions
WO2003054021A3 (en
Inventor
Wouter Van Wyngaardt
Terry Ramodike
Cordelia Mashau
Dubravka Miltiadou
Frances Jordaan
Jeanni Fehrsen
Dion H. Du Plessis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agricultural Research Council
Original Assignee
Agricultural Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Research Council filed Critical Agricultural Research Council
Priority to AU2002359913A priority Critical patent/AU2002359913A1/en
Publication of WO2003054021A2 publication Critical patent/WO2003054021A2/en
Publication of WO2003054021A3 publication Critical patent/WO2003054021A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46Hybrid immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23Immunoglobulins specific features characterized by taxonomic origin from birds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Definitions

  • This invention relates to a semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes. More particularly this invention relates to a large phage-displayed semi-synthetic single chain antibody fragment combinatorial library based on avian immunoglobulin genes.
  • CDR 3 third complementarity determining region of the variable (V) domain of the heavy (H) chains of the antibody fragments are replaced by synthetically randomised peptides.
  • VH variable heavy regions
  • VL variable light
  • VH regions are paired with the natural repertoire of avian VH regions and not with defined light chains, the arrangement being such that combinatorial diversity is contributed by both the variable light (VL) and VH regions and further such that the natural VH repertoire of the avian VH regions adds further diversity.
  • Both modified and unmodified heavy chains may be paired with VL chains from non-immune birds.
  • the specific antibodies are selected by panning on immobilised avian antigens.
  • the antibody fragments may be displayed on large phages.
  • the large phages are filamentous bacteriophages and the antibody fragments may be displayed on the surface of a population of the filamentous bacteriophages.
  • the antibody fragments are single chain antibody fragments.
  • the avian immunoglobulin genes are poultry immunoglobulin genes. Further according to the invention the avian immunoglobulin genes are chicken immunoglobulin genes.
  • a recombinant antibody library according to the invention can be used to bypass the immune system and provide a virtually unlimited repertoire of antibody specificities within a volume of liquid as small as a few microlitres M
  • This invention therefore relates to a "universal" single chain fragment variable (scFv) antibody library from which antibodies of different specificities may be obtained without the need for immunisation.
  • the library is novel in that it is based on avian immunoglobulin genes with the third complementarity determining region (CDR 3) of the variable (V) domain of its heavy (H) chain replaced by a synthetically randomised peptide in some of its members. This adds to its diversity, supplementing that provided by the natural non-immune avian immunoglobulin repertoire.
  • Both modified and unmodified heavy chains are paired with VL light (L) chains from non-immune birds.
  • the resulting repertoire of antibody fragments is displayed on the surface of a population of filamentous bacteriophages. Specific antibodies are selected by panning on immobilised antigens.
  • the library described here is based on chicken immunoglobulin genes. Protection is also sought for similar libraries based on ostrich and other avian immunoglobulin genes.
  • CDR 3 normally plays a major role in determining antibody specificity. While synthetically randomised CDR 3s have been incorporated into a library based on human immunoglobulin genes, its modified VH regions are paired with a single light chain V region specific for bovine serum albumin 3 . In contrast, the library in accordance with the present invention pairs its synthetically randomised VH regions with the natural repertoire of chicken VH regions and not with a defined light chain. Combinatorial diversity is thus contributed by both the VL and VH regions. In addition, it draws on the natural VH repertoire of the chicken to further add diversity.
  • avian immunoglobulin genes Although not commonly used to provide a framework for recombinant antibody library construction, avian immunoglobulin genes have one important advantage; unlike mice and humans, birds use gene conversion of rearranged V(D)J gene sequences to generate antibody diversity 5,7 Nucleotide sequences of the heavy and light chains of chicken immunoglobulins show that virtually all V regions in mature B cells have identical ends. Consequently, these conserved termini make it possible to use PCR to amplify the V region repertoires using a single set of primers for the light chains and another set for the heavy chains 5 . This is in contrast to the mouse or human immunoglobulin genes where a complex and expensive cocktail of primers for each variable region gene family is essential.
  • the library is expected to yield highly specific binding reagents for use in immunoassays for the diagnosis of human, animal and plant disease and for environmental monitoring for e.g. pesticide residues.
  • Suitable antibody fragments can be incorporated any one of a number of immunoassay formats. These include various ELISAs, agglutination assays, immunoblot assays, immunofluorescence and other immunochemical tests. They may also be useful in avian therapeutics.
  • Antibody fragments can also be used in immunoaffinity purification of high value industrial products.
  • the CDR sequences of appropriate antibodies may be able to be transferred to human antibody or other suitable frameworks for medical applications, eg cancer targeting. METHODS
  • the bursa of Fabricius is in birds a reservoir for the avian immune system's diverse repertoire of rearranged and converted V region genes.
  • total RNA was isolated from the bursal lymphocytes of five 3-8 week old non-immunised white leghorn chickens using TRI - Reagent (Molecular Research Center, USA).
  • TRI - Reagent Molecular Research Center, USA.
  • the non-synthetic (i.e. unmodified non- immune) component of the final library the natural repertoire of chicken VH and VL gene sequences was amplified separately and without modification.
  • sets of oligonucleotide primers based on published V region sequences 5,6,8 were designed and used to amplify these regions by means of the polymerase chain reaction (PCR).
  • Primers annealing at the 3' end of the VH and at 5' the end of the VL genes and that included codons for a (Gly Ser) 3 flexible linker 10 were designed with the aim of covalently joining the amplified VH and VL repertoires. These primers overlapped sufficiently with each other in the linker region to permit the repertoires to be joined using splicing by overlap extension (SOE). Once joined, primers annealing at the ends and containing S//1 and Not 1 restriction enzyme sites were next used to amplify by PCR the resulting construct which now encoded the scFv repertoire. This construct was cloned into the appropriate sites in the phagemid vector pHEN and electroporated into E. coli TG 1 cells. Transformants were selected on antibiotic-containing nutrient agar plates. The size of the library was determined by counting appropriate dilutions of antibiotic-resistant colonies. This portion of the library consisted of a total of 3.8 X 10 8 independent clones.
  • VH domain For the second (semi-synthetic) component, synthetic CDR 3s of defined size, but with random sequences were introduced into the VH domain. A set of primers was designed to anneal to the 3' end of the sequence encoding the VH region. These primers incorporated synthetically randomised sequences at the positions that code for the natural chicken VH CDR 3.
  • VH genes with their synthetic CDR 3 repertoires were linked via a separate oligonucleotide coding for the flexible linker to the VL gene repertoire using an SOE protocol similar to that described above.
  • the constructs were ligated into the phagemid display vector pHEN. Transformation and antibiotic selection were as described above.
  • a sublibrary for each size of CDR was constructed.
  • the synthetic CDRs ranged in size from six to 14 amino acid residues.
  • the sublibraries were pooled in appropriate proportions so that each was fully represented.
  • the semi-synthetic portion of the library consisted of approximately 10 9 clones. Sequence analysis of these scFv DNA constructs was performed in order to confirm that the random synthetic CDRs of the predetermined sizes were in fact present.
  • the final phagemid library was obtained by pooling the two major subcomponents (natural and semi-synthetic) described above so that both were fully represented.
  • the pool consists of more thanlO 9 different clones. This figure is not adjusted for out of frame or for non-insert bearing clones.
  • the library was screened by panning 9 on three model antigens (proteins and a hapten).
  • phages displaying the antibody fragment repertoire were rescued by infecting the bacterial phagemid library with M13KO7 helper phages.
  • Each antigen was individually adsorbed passively to the plastic surface of an immunotube (Nunc Maxisorp). Non-specific binding was abrogated by the use of milk powder as a blocking agent.
  • phage displayed antibody fragment library was added and time was allowed for binding. Irrelevant non-binders were removed by washing 20 X with phosphate buffered saline supplemented with 0.1% Tween 20 and another 20 X with PBS. Specifically binding phages were eluted at high pH (pH 12) and amplified by reinfecting TG1 bacterial host cells. Infective phage particles were rescued by co-infection with M13K07 helper phages. After several such rounds of panning, amplification and rescue, the resulting phage were tested and characterised as polyclonal preparations. ELISAs were performed using purified antigens adsorbed to NUNC Polysorp microtitre plates.
  • Milk powder was used as blocking agent.
  • the preparations were adjusted to contain approximately 10 11 phage particles /ml and added to blocked plates. After washing, binding phages were detected by the addition of an anti-M13KO7 mouse monoclonal antibody conjugated to horseradish peroxidase and a chromogenic substrate. Absorbances were determined at 492 nm.
  • Fig 1A illustrates agarose gel electropherograms of the PCR products obtained after amplifying the individual chicken VH and VL sequences which were used to construct the natural non-immune antibody repertoire.
  • Fig 1B shows the product of splicing by overlap extension (SOE) of the VH and VL chain constructs (approx 800 bp). A 10Obp ladder is included in both figures.
  • Fig 2 shows (from left to right) agarose gel electropherograms of the PCR products obtained after amplifying the individual chicken VH (with randomised CDR3), VL and linker sequences.
  • the gel labelled "SOE” shows the product obtained after the aforementioned had been spliced by overlap extension (approx 800bp) and an amplification step that added appropriate restriction sites for phage display cloning.
  • the right-hand track in each gel shows a 100bp marker ladder.
  • Fig 3 illustrates incorporation of synthetically randomised amino acid sequences of three defined sizes into the CDR3 region of the VH frameworks together with part of the framework region and the flexible linker. Only the region into which the defined-length synthetic CDRs were introduced is shown. The unmodified CDRs 1 and 2 and the L chains are not illustrated.
  • ELISA results obtained with polyclonal preparations with a number of model antigens are shown in Fig 4.
  • Test antigens were porcine thyroglobulin, the hapten 4-hydroxy-5-iodo-3-nitrophenylacetic acid (NIP) conjugated to bovine serum albumin and cytochrome c. Phage preparations were tested after each round of selection by panning. The antigen against which the library was panned is given in brackets above each diagram.
  • the X axes show the different panning rounds while the Z axes show the different antigens upon which the selected phage populations were tested. In all cases a population of specifically binding antibodies was selected by round three of the panning procedure.
  • the signal shown with MBP in the bottom graph represents a positive control using a maltose binding protein (MBP) antibody fragment 3 (provided by MRC, Cambridge, UK).
  • MBP maltose binding protein
  • a large universal phage displayed library consisting of more than 10 9 members is described. It has yielded antibodies to a number of different antigens, of which three examples are presented here. Because of its size and diversity, it is expected to yield many more. While it is based on chicken genes, a similar approach can be used in principle for any avian species, provided the relevant VH ant VL region sequences can be amplified. Preliminary results show that his may be possible with the ostrich.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

According to the invention there is provided a semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes. The avian immunoglobulin genes are poultry or chicken immunoglobulin genes. The antibodies are single chain antibody fragments and the library is displayed on large phages. At least some of the third complementarity determining region (CDR 3) of the variable (V) domain of the heavy (H) chains of the antibody fragments are replaced by synthetically randomised peptides. Synthetically randomised variable heavy (VH) regions are paired with the natural repertoire of avian VH regions and not with defined light chains, the arrangement being such that combinatorial diversity is contributed by both the variable light (VL) and VH regions and further such that the natural VH repertoire of the avian VH regions adds further diversity.

Description

SEMI-SYNTHETIC ANTIBODY FRAGMENT COMBINATORIAL LIBRARY
INTRODUCTION
This invention relates to a semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes. More particularly this invention relates to a large phage-displayed semi-synthetic single chain antibody fragment combinatorial library based on avian immunoglobulin genes.
OBJECT OF THE INVENTION It is an object of the present invention to provide a semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes.
SUMMARY OF THE INVENTION
According to the invention there is provided a semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes.
Further according to the invention, at least some of the third complementarity determining region (CDR 3) of the variable (V) domain of the heavy (H) chains of the antibody fragments are replaced by synthetically randomised peptides.
Yet further according to the invention, synthetically randomised variable heavy (VH) regions are paired with the natural repertoire of avian VH regions and not with defined light chains, the arrangement being such that combinatorial diversity is contributed by both the variable light (VL) and VH regions and further such that the natural VH repertoire of the avian VH regions adds further diversity.
Both modified and unmodified heavy chains may be paired with VL chains from non-immune birds.
Preferably the specific antibodies are selected by panning on immobilised avian antigens.
The antibody fragments may be displayed on large phages.
Preferably the large phages are filamentous bacteriophages and the antibody fragments may be displayed on the surface of a population of the filamentous bacteriophages.
Further according to the invention the antibody fragments are single chain antibody fragments.
Further according to the invention the avian immunoglobulin genes are poultry immunoglobulin genes. Further according to the invention the avian immunoglobulin genes are chicken immunoglobulin genes.
A recombinant antibody library according to the invention can be used to bypass the immune system and provide a virtually unlimited repertoire of antibody specificities within a volume of liquid as small as a few microlitresM This invention therefore relates to a "universal" single chain fragment variable (scFv) antibody library from which antibodies of different specificities may be obtained without the need for immunisation. The library is novel in that it is based on avian immunoglobulin genes with the third complementarity determining region (CDR 3) of the variable (V) domain of its heavy (H) chain replaced by a synthetically randomised peptide in some of its members. This adds to its diversity, supplementing that provided by the natural non-immune avian immunoglobulin repertoire.
Both modified and unmodified heavy chains are paired with VL light (L) chains from non-immune birds. The resulting repertoire of antibody fragments is displayed on the surface of a population of filamentous bacteriophages. Specific antibodies are selected by panning on immobilised antigens. The library described here is based on chicken immunoglobulin genes. Protection is also sought for similar libraries based on ostrich and other avian immunoglobulin genes. Uniqueness
Most existing combinatorial antibody libraries are based on either human or mouse immunoglobulin sequences 1_4. Antibody libraries based on chicken immunoglobulin genes have been constructed, but without synthetically randomised sequences5,6 No antibody library based on the ostrich, guinea fowl etc. genes could be located by the Applicant. CDR 3 normally plays a major role in determining antibody specificity. While synthetically randomised CDR 3s have been incorporated into a library based on human immunoglobulin genes, its modified VH regions are paired with a single light chain V region specific for bovine serum albumin3. In contrast, the library in accordance with the present invention pairs its synthetically randomised VH regions with the natural repertoire of chicken VH regions and not with a defined light chain. Combinatorial diversity is thus contributed by both the VL and VH regions. In addition, it draws on the natural VH repertoire of the chicken to further add diversity.
Advantages
Although not commonly used to provide a framework for recombinant antibody library construction, avian immunoglobulin genes have one important advantage; unlike mice and humans, birds use gene conversion of rearranged V(D)J gene sequences to generate antibody diversity5,7 Nucleotide sequences of the heavy and light chains of chicken immunoglobulins show that virtually all V regions in mature B cells have identical ends. Consequently, these conserved termini make it possible to use PCR to amplify the V region repertoires using a single set of primers for the light chains and another set for the heavy chains5. This is in contrast to the mouse or human immunoglobulin genes where a complex and expensive cocktail of primers for each variable region gene family is essential. Incorporating a synthetically randomised CDR3 adds to the natural repertoire since it has not been subjected to biological process (e.g. clonal deletion or affinity maturation) during B cell development. In addition, it allows better control over the construction of the library by incorporating predetermined amounts of a particular CDR 3 size.
Possible applications
The library is expected to yield highly specific binding reagents for use in immunoassays for the diagnosis of human, animal and plant disease and for environmental monitoring for e.g. pesticide residues. Suitable antibody fragments can be incorporated any one of a number of immunoassay formats. These include various ELISAs, agglutination assays, immunoblot assays, immunofluorescence and other immunochemical tests. They may also be useful in avian therapeutics. Antibody fragments can also be used in immunoaffinity purification of high value industrial products. The CDR sequences of appropriate antibodies may be able to be transferred to human antibody or other suitable frameworks for medical applications, eg cancer targeting. METHODS
Construction of the avian antibody library
The bursa of Fabricius is in birds a reservoir for the avian immune system's diverse repertoire of rearranged and converted V region genes. To access this repertoire, total RNA was isolated from the bursal lymphocytes of five 3-8 week old non-immunised white leghorn chickens using TRI - Reagent (Molecular Research Center, USA). To construct the non-synthetic (i.e. unmodified non- immune) component of the final library, the natural repertoire of chicken VH and VL gene sequences was amplified separately and without modification. To achieve this, sets of oligonucleotide primers based on published V region sequences5,6,8 were designed and used to amplify these regions by means of the polymerase chain reaction (PCR). Primers annealing at the 3' end of the VH and at 5' the end of the VL genes and that included codons for a (Gly Ser)3 flexible linker10 were designed with the aim of covalently joining the amplified VH and VL repertoires. These primers overlapped sufficiently with each other in the linker region to permit the repertoires to be joined using splicing by overlap extension (SOE). Once joined, primers annealing at the ends and containing S//1 and Not 1 restriction enzyme sites were next used to amplify by PCR the resulting construct which now encoded the scFv repertoire. This construct was cloned into the appropriate sites in the phagemid vector pHEN and electroporated into E. coli TG 1 cells. Transformants were selected on antibiotic-containing nutrient agar plates. The size of the library was determined by counting appropriate dilutions of antibiotic-resistant colonies. This portion of the library consisted of a total of 3.8 X 108 independent clones.
For the second (semi-synthetic) component, synthetic CDR 3s of defined size, but with random sequences were introduced into the VH domain. A set of primers was designed to anneal to the 3' end of the sequence encoding the VH region. These primers incorporated synthetically randomised sequences at the positions that code for the natural chicken VH CDR 3. After amplification by PCR, the VH genes with their synthetic CDR 3 repertoires were linked via a separate oligonucleotide coding for the flexible linker to the VL gene repertoire using an SOE protocol similar to that described above. After amplification (see above), the constructs were ligated into the phagemid display vector pHEN. Transformation and antibiotic selection were as described above. A sublibrary for each size of CDR was constructed. The synthetic CDRs ranged in size from six to 14 amino acid residues. The sublibraries were pooled in appropriate proportions so that each was fully represented. The semi-synthetic portion of the library consisted of approximately 109 clones. Sequence analysis of these scFv DNA constructs was performed in order to confirm that the random synthetic CDRs of the predetermined sizes were in fact present.
The final phagemid library was obtained by pooling the two major subcomponents (natural and semi-synthetic) described above so that both were fully represented. The pool consists of more thanlO9 different clones. This figure is not adjusted for out of frame or for non-insert bearing clones.
Screening for antigen-specific binders
To prove its usefulness as a source of antibody fragments that recognise disparate antigens, the library was screened by panning 9 on three model antigens (proteins and a hapten). First, phages displaying the antibody fragment repertoire were rescued by infecting the bacterial phagemid library with M13KO7 helper phages. Each antigen was individually adsorbed passively to the plastic surface of an immunotube (Nunc Maxisorp). Non-specific binding was abrogated by the use of milk powder as a blocking agent.
A representative aliquot of the phage displayed antibody fragment library was added and time was allowed for binding. Irrelevant non-binders were removed by washing 20 X with phosphate buffered saline supplemented with 0.1% Tween 20 and another 20 X with PBS. Specifically binding phages were eluted at high pH (pH 12) and amplified by reinfecting TG1 bacterial host cells. Infective phage particles were rescued by co-infection with M13K07 helper phages. After several such rounds of panning, amplification and rescue, the resulting phage were tested and characterised as polyclonal preparations. ELISAs were performed using purified antigens adsorbed to NUNC Polysorp microtitre plates. Milk powder was used as blocking agent. The preparations were adjusted to contain approximately 1011 phage particles /ml and added to blocked plates. After washing, binding phages were detected by the addition of an anti-M13KO7 mouse monoclonal antibody conjugated to horseradish peroxidase and a chromogenic substrate. Absorbances were determined at 492 nm.
RESULTS Construction
Natural repertoire component
Fig 1A illustrates agarose gel electropherograms of the PCR products obtained after amplifying the individual chicken VH and VL sequences which were used to construct the natural non-immune antibody repertoire. Fig 1B shows the product of splicing by overlap extension (SOE) of the VH and VL chain constructs (approx 800 bp). A 10Obp ladder is included in both figures.
Semi-synthetic repertoire component
Fig 2 shows (from left to right) agarose gel electropherograms of the PCR products obtained after amplifying the individual chicken VH (with randomised CDR3), VL and linker sequences. The gel labelled "SOE" shows the product obtained after the aforementioned had been spliced by overlap extension (approx 800bp) and an amplification step that added appropriate restriction sites for phage display cloning. The right-hand track in each gel shows a 100bp marker ladder.
Sequence analysis
Fig 3 illustrates incorporation of synthetically randomised amino acid sequences of three defined sizes into the CDR3 region of the VH frameworks together with part of the framework region and the flexible linker. Only the region into which the defined-length synthetic CDRs were introduced is shown. The unmodified CDRs 1 and 2 and the L chains are not illustrated.
Screening to prove that binders are present
ELISA results obtained with polyclonal preparations with a number of model antigens are shown in Fig 4. Test antigens were porcine thyroglobulin, the hapten 4-hydroxy-5-iodo-3-nitrophenylacetic acid (NIP) conjugated to bovine serum albumin and cytochrome c. Phage preparations were tested after each round of selection by panning. The antigen against which the library was panned is given in brackets above each diagram. The Y axes depict the A 4g2 ELISA values. The X axes show the different panning rounds while the Z axes show the different antigens upon which the selected phage populations were tested. In all cases a population of specifically binding antibodies was selected by round three of the panning procedure. The signal shown with MBP in the bottom graph represents a positive control using a maltose binding protein (MBP) antibody fragment3 (provided by MRC, Cambridge, UK). DISCUSSION
A large universal phage displayed library consisting of more than 109 members is described. It has yielded antibodies to a number of different antigens, of which three examples are presented here. Because of its size and diversity, it is expected to yield many more. While it is based on chicken genes, a similar approach can be used in principle for any avian species, provided the relevant VH ant VL region sequences can be amplified. Preliminary results show that his may be possible with the ostrich.
It will be appreciated that variations in detail are possible with a semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes according to the invention without departing from the scope of the appended claims.

Claims

1. A semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes.
2. A semi-synthetic antibody fragment combinatorial library according to claim 1 wherein at least some of the third complementarity determining region (CDR 3) of the variable (V) domain of the heavy (H) chains of the antibody fragments are replaced by synthetically randomised peptides.
3. A semi-synthetic antibody fragment combinatorial library according to claim 2 wherein synthetically randomised variable heavy (VH) regions are paired with the natural repertoire of avian VH regions and not with defined light chains, the arrangement being such that combinatorial diversity is contributed by both the variable light (VL) and VH regions and further such that the natural VH repertoire of the avian VH regions adds further diversity.
4. A semi-synthetic antibody fragment combinatorial library according to claim 3 wherein both modified and unmodified heavy chains are paired with VL chains from non-immune birds.
5. A semi-synthetic antibody fragment combinatorial library according to any one of the preceding claims wherein the specific antibodies are selected by panning on immobilised avian antigens.
6. A semi-synthetic antibody fragment combinatorial library according to any one of the preceding claims wherein the antibody fragments are displayed on large phages.
7. A semi-synthetic antibody fragment combinatorial library according to claim 6 wherein the large phages are filamentous bacteriophages and wherein the antibody fragments are displayed on the surface of a population of the filamentous bacteriophages.
8. A semi-synthetic antibody fragment combinatorial library according to any one of the preceding claims wherein the antibody fragments are single chain antibody fragments.
9. A semi-synthetic antibody fragment combinatorial library according to any one of the preceding claims wherein the avian immunoglobulin genes are poultry immunoglobulin genes.
10. A semi-synthetic antibody fragment combinatorial library according to claim 9 wherein the avian immunoglobulin genes are chicken immunoglobulin genes.
1. A semi-synthetic antibody fragment combinatorial library substantially as herein described and exemplified.
PCT/ZA2002/000218 2001-12-20 2002-12-20 Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes Ceased WO2003054021A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002359913A AU2002359913A1 (en) 2001-12-20 2002-12-20 Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200110456 2001-12-20
ZA2001/10456 2001-12-20

Publications (2)

Publication Number Publication Date
WO2003054021A2 true WO2003054021A2 (en) 2003-07-03
WO2003054021A3 WO2003054021A3 (en) 2004-02-12

Family

ID=25589412

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ZA2002/000218 Ceased WO2003054021A2 (en) 2001-12-20 2002-12-20 Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes

Country Status (2)

Country Link
AU (1) AU2002359913A1 (en)
WO (1) WO2003054021A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1930346A4 (en) * 2005-08-29 2009-04-08 Japan Science & Tech Agency ANTIBODY OBTAINED BY USING AN OSTRICH AND METHOD FOR PRODUCING THE SAME
WO2014016737A1 (en) * 2012-07-24 2014-01-30 Pfizer Inc. Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7262700A (en) * 1999-09-07 2001-04-10 Viventia Biotech Inc. Enhanced phage display library of human vh fragments and methods for producing same
IT1307309B1 (en) * 1999-12-30 2001-10-30 Enea Ente Nuove Tec STABILIZING PEPTIDES, POLYPEPTIDES AND ANTIBODIES THAT INCLUDE THEM.
WO2001088162A2 (en) * 2000-05-16 2001-11-22 Genway Biotech, Inc. Methods and vectors for generating antibodies in avian species and uses therefor
IL136459A0 (en) * 2000-05-30 2001-06-14 Galim Galil Immunology Ltd Antibody library
AUPR546801A0 (en) * 2001-06-05 2001-06-28 Commonwealth Scientific And Industrial Research Organisation Recombinant antibodies
AU2002324973A1 (en) * 2001-09-14 2003-04-01 Fraunhofer-Gesellschaft Zur Forderung Der Angewandandten Forschung E.V. Immunoglobulin having particular framework scaffold and methods of making and using

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1930346A4 (en) * 2005-08-29 2009-04-08 Japan Science & Tech Agency ANTIBODY OBTAINED BY USING AN OSTRICH AND METHOD FOR PRODUCING THE SAME
US8765133B2 (en) 2005-08-29 2014-07-01 Japan Science And Technology Agency Method of producing anti-CD166 antibody in ostrich
US8815244B2 (en) 2005-08-29 2014-08-26 Japan Science And Technology Agency Method for production of antibody using ostrich
WO2014016737A1 (en) * 2012-07-24 2014-01-30 Pfizer Inc. Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof

Also Published As

Publication number Publication date
AU2002359913A8 (en) 2003-07-09
WO2003054021A3 (en) 2004-02-12
AU2002359913A1 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
Pansri et al. A compact phage display human scFv library for selection of antibodies to a wide variety of antigens
US7709219B2 (en) Compositions and methods for detection of antibody binding to cells
Azzazy et al. Phage display technology: clinical applications and recent innovations
JP3507073B2 (en) Methods for producing members of a specific binding pair
EP1133565B1 (en) Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
Andris-Widhopf et al. Methods for the generation of chicken monoclonal antibody fragments by phage display
Williams et al. Identification of epitopes within beta lactoglobulin recognised by polyclonal antibodies using phage display and PEPSCAN
Bradbury et al. Use of living columns to select specific phage antibodies
KR100961392B1 (en) Method for producing antibody phage surface presentation library, antibody phage surface presentation library prepared by the method, phagemid vector comprising the antibody phage surface presentation library gene
Deng et al. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system
Tesar et al. Monoclonal antibody against pIII of filamentous phage: an immunological tool to study pIII fusion protein expression in phage display systems
US20060275811A1 (en) Method for producing target substance capturing protein and method for selecting component materials thereof
Hust et al. Selection of recombinant antibodies from antibody gene libraries
Eteshola Isolation of scFv fragments specific for monokine induced by interferon-gamma (MIG) using phage display
US9951121B2 (en) Phage displaying system expressing single chain antibody
Mersmann et al. Monitoring of scFv selected by phage display using detection of scFv–pIII fusion proteins in a microtiter scale assay
Kabir et al. An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody
Yan et al. Generation and characterization of a novel single-chain antibody fragment specific against human fibrin clots from phage display antibody library
de Greeff et al. Selection of recombinant antibodies specific for pathogenic Streptococcus suis by subtractive phage display
WO2003054021A2 (en) Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes
Barbas et al. Filamentous phage display
KR100458083B1 (en) Method for the construction of phage display library using helper phage variants
Cao et al. Neutralizing human anti-B-cell-activating factor of the TNF family (BAFF) scFv selected from phage antibody library
Rader Generation and Selection of Phage Display Antibody Libraries in Fab Format
Leow et al. Monoclonal IgY antibodies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004/05434

Country of ref document: ZA

Ref document number: 200405434

Country of ref document: ZA

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP